Xoma reported $86K in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Agenus AGEN:US USD 2.95M 120K
Agios Pharmaceuticals AGIO:US USD 71K 0
Ardelyx ARDX:US USD 19K 4K
Biomarin Pharmaceutical BMRN:US USD 186K 0
Bluebird Bio BLUE:US USD 829K 94K
Celldex Therapeutics CLDX:US USD 47K 0
Chimerix CMRX:US USD 88K 1000
Curis CRIS:US USD 964K 46K
Eli Lilly And LLY:US USD 594.1M 0
Emergent Biosolutions EBS:US USD 100K 0
Intercept Pharmaceuticals ICPT:US USD 41K 11K
Life Technologies LIFE:US USD 29K 1000
Macrogenics MGNX:US USD 615K 0
Novartis NVS:US USD 890M 0
Novartis NOVN:VX USD 890M 0
Prothena PRTA:US USD 479K 11K
Regeneron Pharmaceuticals REGN:US USD 100K 0
Teva Pharmaceutical Industries TEVA:US USD 57M 0
Xoma XOMA:US USD 86K 0